Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 15
Phase 24

Trial Status

Completed5

Role Distribution

Principal Investigator5
PI Rate100%

Activity Timeline

Clinical Trials (5)

NCT04689282Phase 1/2Completed
Intranasal Inhalations of M2 Macrophage Soluble Factors in Children With Developmental Speech Disorders
Attention Deficit-Hyperactivity DisorderAutism Spectrum DisorderLanguage Delay+3 more
PrincipalinvestigatorStart date: 2020-02-01
NCT03337165Phase 1Completed
Autologous Tolerogenic Dendritic Cells for Treatment of Patients With Rheumatoid Arthritis
ArthritisArthritis, RheumatoidAutoimmune Diseases+5 more
PrincipalinvestigatorStart date: 2016-12-01
NCT02957123Phase 1/2Completed
Intranasal Inhalations of Bioactive Factors Produced by M2 Macrophages in Patients With Organic Brain Syndrome
Brain IschemiaDelirium, Dementia, Amnestic, Cognitive DisordersEncephalopathy, Ischemic+6 more
PrincipalinvestigatorStart date: 2016-03-01
NCT03119025Phase 1/2Completed
Autologous Dendritic Cell Vaccine for Treatment of Patients With Chronic HCV-Infection
HepatitisHepatitis C, ChronicLiver Diseases+1 more
PrincipalinvestigatorStart date: 2015-05-01
NCT02967874Phase 1/2Completed
Autologous Adipose-Derived Stromal Vascular Fraction Cells for Osteoarthritis Treatment
Arthritis, DegenerativeJoint DiseaseOsteoarthritis+3 more
Principalinvestigator

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Elena R Chernykh, MD, PhD

Institute of Fundamental and Clinical Immunology

Very Similar
5 trials

Shared therapeutic areas:

Joint DiseasesArthritisOsteoarthritis+23 more

Worked with same sponsors:

Russian Academy of Medical Sciences
Collaborated on 5 trials
Similarity Score280%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

Autism Spectrum DisorderArthritisArthritis, Rheumatoid
Similarity Score3%

Michael B Gill

Power Life Sciences Inc.

Related
105 trials

Shared therapeutic areas:

Musculoskeletal DiseasesOsteoarthritisArthritis, Rheumatoid
Similarity Score3%

Hassan Achakri

Zimmer Biomet

Related
23 trials

Shared therapeutic areas:

Arthritis, RheumatoidOsteoarthritisJoint Diseases
Similarity Score3%

Hamid Gourabi, PhD

head of Royan Institute

Related
52 trials

Shared therapeutic areas:

OsteoarthritisArthritis, Rheumatoid
Similarity Score2%

Jeong Min Lee, MD

Seoul National University Hospital

Related
34 trials

Shared therapeutic areas:

HepatitisLiver Diseases
Similarity Score2%

Alan Kivitz, MD

Altoona Center for Clinical Research

Related
7 trials

Shared therapeutic areas:

Arthritis, RheumatoidOsteoarthritis
Similarity Score2%

Joseph Biederman, MD

Massachusetts General Hospital

Related
24 trials

Shared therapeutic areas:

Attention Deficit Disorder with HyperactivityAutism Spectrum Disorder
Similarity Score2%

Robert B Innis, M.D.

National Institute of Mental Health (NIMH)

Related
35 trials

Shared therapeutic areas:

Autism Spectrum DisorderArthritis, Rheumatoid
Similarity Score2%

Susan Shur-Fen Gau, MD, PhD

National Taiwan University Hospital & College of Medicine

Related
23 trials

Shared therapeutic areas:

Attention Deficit Disorder with HyperactivityAutism Spectrum Disorder
Similarity Score2%

Publications (0)

No publications found for this investigator.

Clinical Trials (5)

Showing 5 of 5 trials

NCT04689282Phase 1/2PrincipalInvestigator

Intranasal Inhalations of M2 Macrophage Soluble Factors in Children With Developmental Speech Disorders

Attention Deficit-Hyperactivity DisorderAutism Spectrum DisorderLanguage Delay+3 more
Completed
NCT03337165Phase 1PrincipalInvestigator

Autologous Tolerogenic Dendritic Cells for Treatment of Patients With Rheumatoid Arthritis

ArthritisArthritis, RheumatoidAutoimmune Diseases+5 more
Completed
NCT02957123Phase 1/2PrincipalInvestigator

Intranasal Inhalations of Bioactive Factors Produced by M2 Macrophages in Patients With Organic Brain Syndrome

Brain IschemiaDelirium, Dementia, Amnestic, Cognitive DisordersEncephalopathy, Ischemic+6 more
Completed
NCT03119025Phase 1/2PrincipalInvestigator

Autologous Dendritic Cell Vaccine for Treatment of Patients With Chronic HCV-Infection

HepatitisHepatitis C, ChronicLiver Diseases+1 more
Completed
NCT02967874Phase 1/2PrincipalInvestigator

Autologous Adipose-Derived Stromal Vascular Fraction Cells for Osteoarthritis Treatment

Arthritis, DegenerativeJoint DiseaseOsteoarthritis+3 more
Completed

All 5 trials loaded